Individuals with mutations in BRCA1 or BRCA2 have a predisposition to develop breast cancer, ovarian cancer and prostate cancer, as well as other cancers. Opaldia offers specific mutations screens as well as whole gene & rearrangement analyses.
Mutation analysis may be population-specific and include mutations known to be found at greater frequencies in certain ethnicities, for example, in the Ashkenazi Jewish population. Furthermore, known family-specific mutations will target only a single mutation known to segregate with cancer within a given family.